Standardizing objective neuropathy assessments and definitions of clinically significant PIPN across studies would enable cross-trial comparisons
No artificial color, artificial flavor, artificial sweetener, preservatives, sugar, starch, milk, lactose, gluten, wheat, yeast, fish
Supplement Facts: Serving Size: 12.5 ml Servings Per Container: 40 Amount Per Serving: L-Carnitine: 1500 mg Protein: 0 g Carbohydrate: 0 g of which sugars: 0 g Fat: 0 g of which saturates: 0 g Fibre: 0 g Salt: 0 g *RI - Reference Intake Ingredients: Water, citric acid, flavourings, preservative potassium sorbate, thickening agent cellulose gum, carrot and blackcurrant concentrate for color, coloring for apricot flavor beta-carotene, sodium benzoate
The Solution: Set a daily alarm and commit to a 30-minute window for administration
Here we have used PV VLPs as a clinically relevant model system to better understand the GSH-binding site as a druggable pocket for the development of antivirals against EVs and as a site for the potential stabilisation of synthetic vaccine candidates